MRKR

NASDAQStock

Marker Therapeutics, Inc.

$1.33-0.02 (-1.48%)

52-Week Range

$0.85

$2.19

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.45

Volume

64.0K

Avg Volume

133.9K

Performance

-6.25%

-2.88%

+42.72%

YTD

-12.34%

+9.31%

-31.82%

-92.89%

Price Chart

ETF Exposure

MRKR is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	12	$27	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	458	$994	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	2	$4	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	261,243	$418K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	1,374	$3K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	118	$256	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	95,817	$153K	$84.10B	0.05%

About MRKR ETF Exposure

Marker Therapeutics, Inc. (MRKR) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $1.33. Investors can gain exposure to MRKR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold MRKR, sorted by portfolio weight.